Disha Malani - Concepedia

Author

Disha Malani

Institute for Molecular Medicine Finland ORCID

Also Known As

D Malani, Disha Malani, Disha, Malani

112

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Institute for Molecular Medicine Finland University of Helsinki Helsinki University Hospital University of Turku Science for Life Laboratory

About

Disha Malani is an author at Institute for Molecular Medicine Finland specializing in medicine, immunology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	408
2	Immunology	2	2	236
3	Pharmacology	2	2	142
4	Cell Biology	1	1	80
5	Pathology	1	1	186

Disha Malani

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies Bhagwan Yadav, Tea Pemovska, Agnieszka Szwajda, Scientific Reports	2014	357
Immunogenomic Landscape of Hematological Malignancies Olli Dufva, Petri Pölönen, Oscar Brück, Cancer Cell Hematological MalignancyCancer ImmunosurveillanceMedicineMalignant Blood DisorderHematology	2020	186
Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia Disha Malani, Ashwini Kumar, Oscar Brück, Cancer Discovery	2021	182
Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target Olli Dufva, Matti Kankainen, Tiina Kelkka, Nature Communications	2018	139
Drug response prediction by inferring pathway-response associations with kernelized Bayesian matrix factorization Muhammad Ammad-ud-din, Suleiman A. Khan, Disha Malani, Bioinformatics	2016	120
Consistency in drug response profiling John Patrick Mpindi, Bhagwan Yadav, Päivi Östling, Nature MedicineResponse PredictionDrug Response ProfilingDrug AssessmentPharmacology	2016	92
HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia Mika Kontro, Ashwini Kumar, Muntasir Mamun Majumder, Leukemia Hematological MalignancyHox Gene ExpressionMixed-phenotype Acute LeukemiaAcute Myeloid LeukemiaMalignant Blood Disorder	2016	80
Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML Disha Malani, Astrid Murumägi, Bhagwan Yadav, Leukemia Hematological MalignancyChemorefractory Aml PatientsOncologyMedicineAcute Myeloid Leukemia	2016	50
Hemap: An Interactive Online Resource for Characterizing Molecular Phenotypes across Hematologic Malignancies Petri Pölönen, Juha Mehtonen, Jake Lin, Cancer Research	2019	37
Bayesian multi-source regression and monocyte-associated gene expression predict BCL-2 inhibitor resistance in acute myeloid leukemia Brian S. White, Suleiman A. Khan, Mike J. Mason, npj Precision Oncology	2021	31

Page 1